{"filing":{"accession_number":"0001193125-26-257379","cik":"0001598646","ticker":"NERV","company_name":"Minerva Neurosciences, Inc.","form":"8-K","filing_date":"2026-06-04","report_date":null,"primary_document":"d57321d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1598646/000119312526257379/d57321d8k.htm"},"events":[{"id":6799,"run_id":5957,"accession_number":"0001193125-26-257379","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"Minerva Neurosciences held its 2026 Annual Meeting of Stockholders on June 3, 2026, with shareholders voting on six proposals including director elections, charter amendments, advisory compensation votes, and auditor ratification. All proposals were approved by stockholders.","company_name":"Minerva Neurosciences, Inc.","ticker":"NERV","filing_date":"2026-06-04","form":"8-K","submitted_at":null,"items":[{"id":4327,"accession_number":"0001193125-26-257379","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure of shareholder meeting results. The filing reports voting outcomes for six proposals at Minerva Neurosciences' 2026 Annual Meeting held June 3, 2026, including director elections, charter amendments, advisory compensation votes, and auditor ratification. The detailed vote tallies and stockholder approval of all proposals are the core content of the disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T04:57:07.463745+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":6800,"run_id":5957,"accession_number":"0001193125-26-257379","anchor_item_number":"5.03","event_type":"other_material","event_domain":"catchall","is_material":false,"confidence":0.85,"summary":"The Company's Certificate of Incorporation and Bylaws were amended, approved at the 2026 Annual Meeting, including exculpation provisions for officers, elimination of exclusive forum provisions, and updates to advance notice and stockholder meeting procedures. These are routine governance and procedural amendments.","company_name":"Minerva Neurosciences, Inc.","ticker":"NERV","filing_date":"2026-06-04","form":"8-K","submitted_at":null,"items":[{"id":4325,"accession_number":"0001193125-26-257379","item_number":"3.03","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.45,"reasoning":"Item 3.03 discloses a material modification to rights of security holders, with the substance incorporated by reference from Item 5.03 (amendments to articles of incorporation or bylaws). Without access to the Item 5.03 content, the specific nature of the modification cannot be determined. The filing indicates a material change to security holder rights, but the event type cannot be confidently assigned to a more specific category without knowing whether this involves a charter amendment, voting rights change, or other structural modification.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T04:57:07.463745+00:00","company_name":"","ticker":null,"filing_date":""},{"id":4326,"accession_number":"0001193125-26-257379","item_number":"5.03","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":false,"confidence":0.85,"reasoning":"This Item 5.03 discloses amendments to the Company's Certificate of Incorporation and Bylaws approved at the 2026 Annual Meeting, including exculpation provisions for officers, elimination of exclusive forum provisions, and updates to advance notice and stockholder meeting procedures. While these are governance changes, they are routine administrative and procedural amendments that do not affect the registrant's financial condition, operations, or material business prospects—the hallmark of non-material disclosures under Item 5.03.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T04:57:07.463745+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":4325,"accession_number":"0001193125-26-257379","item_number":"3.03","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.45,"reasoning":"Item 3.03 discloses a material modification to rights of security holders, with the substance incorporated by reference from Item 5.03 (amendments to articles of incorporation or bylaws). Without access to the Item 5.03 content, the specific nature of the modification cannot be determined. The filing indicates a material change to security holder rights, but the event type cannot be confidently assigned to a more specific category without knowing whether this involves a charter amendment, voting rights change, or other structural modification.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T04:57:07.463745+00:00","company_name":"Minerva Neurosciences, Inc.","ticker":"NERV","filing_date":"2026-06-04"},{"id":4326,"accession_number":"0001193125-26-257379","item_number":"5.03","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":false,"confidence":0.85,"reasoning":"This Item 5.03 discloses amendments to the Company's Certificate of Incorporation and Bylaws approved at the 2026 Annual Meeting, including exculpation provisions for officers, elimination of exclusive forum provisions, and updates to advance notice and stockholder meeting procedures. While these are governance changes, they are routine administrative and procedural amendments that do not affect the registrant's financial condition, operations, or material business prospects—the hallmark of non-material disclosures under Item 5.03.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T04:57:07.463745+00:00","company_name":"Minerva Neurosciences, Inc.","ticker":"NERV","filing_date":"2026-06-04"},{"id":4327,"accession_number":"0001193125-26-257379","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure of shareholder meeting results. The filing reports voting outcomes for six proposals at Minerva Neurosciences' 2026 Annual Meeting held June 3, 2026, including director elections, charter amendments, advisory compensation votes, and auditor ratification. The detailed vote tallies and stockholder approval of all proposals are the core content of the disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T04:57:07.463745+00:00","company_name":"Minerva Neurosciences, Inc.","ticker":"NERV","filing_date":"2026-06-04"}]}